8-K: Aemetis Q2 2025: Revenue Up, Losses Narrow

Aemetis reports increased Q2 2025 revenue to $52.2 million driven by India biodiesel and Biogas growth, alongside improved operating and net losses.

Summary

• Q2 2025 revenues were $52.2 million, an increase of $9.3 million from Q1 2025 revenues of $42.9 million, but a decrease from $66.6 million in Q2 2024.
• H1 2025 revenues were $95.1 million, down from $139.2 million in H1 2024, primarily due to delays in India government contracts.
• Operating loss for Q2 2025 improved to $10.7 million from $13.6 million in Q2 2024.
• Net loss for Q2 2025 improved to $23.4 million from $29.2 million in Q2 2024.
• Aemetis Biogas recognized $3.1 million in revenue from 11 operating dairy digesters in Q2 2025, producing 106,400 MMBtu.
• India Biodiesel business recognized $11.9 million of revenue in Q2 2025 from new sales to India Oil Marketing Companies.
• Signed a $27 million agreement with NPL to construct HS and compression units for 15 dairy digesters.
• Selling, general and administrative expenses significantly decreased to $7.3 million in Q2 2025 from $11.8 million in Q2 2024, partly due to a $3.6 million loss on asset disposals in Q2 2024.
• Cash at the end of Q2 2025 was $1.6 million, up from $900 thousand at the close of 2024.
• Investments in capital projects totaled $3.6 million for Q2 2025 and $5.4 million for H1 2025.
• A new CFO with IPO experience was appointed for the India subsidiary, which is targeting a public listing in early 2026.
• CARB approved 7 new Low Carbon Fuel Standard (LCFS) pathways in Q2.
• Federal Section 45Z production tax credits were extended to year 2029.

Sentiment

Score: 6

Explanation: While the company continues to incur significant losses and faces challenges like year-over-year revenue decline and increased current liabilities, there are clear signs of operational improvements (sequential revenue growth, reduced SG&A, improved Q2 losses) and strategic progress (Biogas expansion, new contracts, tax credit extension, India IPO plans). The positive developments in the Biogas and India segments, coupled with the extension of key tax credits, provide a cautiously optimistic outlook despite the financial challenges.

Positives

• Q2 2025 revenue increased by $9.3 million from Q1 2025, reflecting sequential growth.
• Operating loss improved by $2.9 million in Q2 2025 compared to Q2 2024.
• Net loss improved by $5.8 million in Q2 2025 compared to Q2 2024, and by $5.5 million in H1 2025 compared to H1 2024.
• Selling, general and administrative expenses significantly decreased by $4.5 million in Q2 2025 compared to Q2 2024.
• Restart of India biodiesel deliveries under new orders from Oil Marketing Companies contributed to revenue.
• Aemetis Biogas production and revenue continued to grow, with $3.1 million from 11 digesters in Q2 2025.
• Signed a $27 million agreement with NPL for construction of HS and compression units for 15 dairy digesters.
• CARB approved 7 new LCFS pathways in Q2, expected to generate additional revenues.
• Federal Section 45Z production tax credits were extended to 2029, providing long-term financial benefits.
• Appointment of a new CFO for the India subsidiary with IPO experience supports the target for an early 2026 public listing.
• Cash position improved to $1.6 million at quarter-end from $900 thousand at year-end 2024.
• Progress on the mechanical vapor recompression project is expected to significantly increase Section 45Z tax credit income and operating cash flow by reducing natural gas consumption.

Negatives

• Total revenues for Q2 2025 decreased to $52.2 million from $66.6 million in Q2 2024.
• Total revenues for H1 2025 significantly decreased to $95.1 million from $139.2 million in H1 2024.
• Gross loss widened to $3.4 million in Q2 2025 from $1.8 million in Q2 2024, and to $8.4 million in H1 2025 from $2.4 million in H1 2024.
• Operating loss for H1 2025 worsened to $26.2 million from $23.1 million in H1 2024.
• Interest expense increased slightly to $12.3 million in Q2 2025 from $11.7 million in Q2 2024, and to $26.0 million in H1 2025 from $22.2 million in H1 2024.
• The Keyes plant operated at a slightly lower grind rate in Q2 2025.
• India Biodiesel metric tons sold significantly decreased to 9.4 thousand in Q2 2025 from 20.4 thousand in Q2 2024, and to 9.4 thousand in H1 2025 from 47.5 thousand in H1 2024.
• Average sales price for India Biodiesel decreased to $1,010 per metric ton in Q2 2025 from $1,162 in Q2 2024.
• Average price per RIN decreased to $2.60 in Q2 2025 from $3.17 in Q2 2024.
• Average price per LCFS credit decreased to $55.25 in Q2 2025 from $64.75 in Q2 2024.
• Current portion of long-term debt significantly increased to $247.6 million at June 30, 2025, from $63.7 million at December 31, 2024.
• Total current liabilities increased to $321.9 million at June 30, 2025, from $143.9 million at December 31, 2024.
• Total stockholders' deficit worsened to $(289.2) million at June 30, 2025, from $(263.9) million at December 31, 2024.

Risks

• Competition in the ethanol, biodiesel, and other industries in which the company operates.
• Commodity market risks, including those that may result from current weather conditions.
• Financial market risks.
• Customer adoption risks.
• Counter-party risks.
• Risks associated with changes to federal policy or regulation.
• Ability to fund, develop, build, maintain, and operate digesters, facilities, and pipelines for the dairy renewable natural gas segment.
• Ability to fund, develop, and operate Sustainable Aviation Fuel (SAF), renewable diesel, and carbon capture and sequestration projects, including obtaining required permits.
• Ability to receive awarded grants by meeting all of the required conditions, including meeting minimum contributions.
• Intention to repurchase the Series A preferred units relating to the Aemetis Biogas subsidiary and the expected valuation premium thereof.
• Ability to raise additional capital.

Future Outlook

The company anticipates additional revenues from seven newly CARB-approved dairy digester Renewable Natural Gas (RNG) pathways and from federal Section 45Z production tax credits, which were extended to 2029. Operating cash flow and Section 45Z tax credit income in the California Ethanol segment are expected to significantly increase due to the mechanical vapor recompression project. A large dairy digester is expected to be completed in August 2025, and the India subsidiary is targeting a public listing in early 2026.

Management Comments

• Todd Waltz, CFO: "Revenues of $52.2 million during the second quarter of 2025 are an increase of $9.3 million from the $42.9 million revenues during the first quarter of 2025, reflecting continued execution by our California Ethanol and Dairy Renewable Natural Gas segments, along with the fulfillment of new India Oil Marketing Companies orders."
• Todd Waltz, CFO: "We look forward to additional revenues from the seven dairy digester RNG pathways recently approved by CARB and the revenues from federal Section 45Z production tax credits that were extended to year 2029 in the One Big Beautiful Bill Act."
• Eric McAfee, Chairman and CEO: "We are pleased with the continued growth of Aemetis Biogas production and continued progress with building a large dairy digester to process waste from multiple dairies, which is already producing biogas and will be completed in August."
• Eric McAfee, Chairman and CEO: "The Section 45Z tax credit income and operating cash flow is expected to be significantly increased in our California Ethanol segment by reducing natural gas consumption with the mechanical vapor recompression project that has completed several steps of fabrication and construction."

Industry Context

The company operates in the renewable natural gas, renewable fuels (ethanol, biodiesel, Sustainable Aviation Fuel), and biochemicals sectors. Its focus on low and negative carbon intensity products aligns with global trends towards decarbonization and sustainable energy. The expansion of dairy digester networks addresses agricultural waste and methane emissions, a key area in renewable natural gas. The development of SAF and renewable diesel biorefinery indicates a strategic move towards higher-value, in-demand renewable fuels, supported by regulatory incentives like CARB LCFS pathways and federal Section 45Z tax credits.

Comparison to Industry Standards

• No specific comparable companies, projects, or results were mentioned in the filing for direct assessment against global benchmarks.

Management Changes

Stakeholder Impact

• Shareholders: Continued losses and increased debt are concerns, but strategic progress in Biogas and India, along with potential future profitability from new projects and tax credits, offer long-term upside. The India subsidiary IPO could unlock value.
• Employees: Ongoing operations and project development suggest stable employment, particularly in California and India.
• Customers: Continued supply of ethanol, biodiesel, and RNG, with expansion plans indicating increased capacity and product offerings.
• Suppliers: Ongoing operations and new construction projects (e.g., $27 million agreement with NPL) indicate continued demand for supplies and services.
• Creditors: Significant increase in current portion of long-term debt and overall current liabilities could be a concern, but improved operating performance and future revenue streams could mitigate risk.

Next Steps

• Completion of a large dairy digester in August 2025.
• Realization of additional revenues from 7 newly CARB-approved dairy digester RNG pathways.
• Increased Section 45Z tax credit income and operating cash flow from the mechanical vapor recompression project.
• India subsidiary targeting a public listing in early 2026.

Key Dates

Recommendation

While Aemetis shows promising operational progress in its Biogas and India segments, with sequential revenue growth and improved Q2 losses, the company continues to report substantial net losses and has seen a significant increase in current liabilities, particularly the current portion of long-term debt. The year-over-year revenue decline for both Q2 and H1, coupled with widening gross losses, indicates ongoing challenges in achieving consistent profitability. The strategic initiatives, such as the India subsidiary IPO target and the $27 million agreement for dairy digesters, offer future growth potential and could unlock value. However, the current financial position warrants caution. A 'Hold' recommendation is appropriate as investors should monitor the execution of these strategic projects and the company's ability to manage its debt and transition to sustained profitability before considering further investment.

Keywords

Renewable Natural Gas, RNG, Biodiesel, Ethanol, SAF, Sustainable Aviation Fuel, LCFS, Low Carbon Fuel Standard, Dairy Digesters, Biogas, Carbon Intensity, Aemetis, AMTX, Financial Results, Renewable Fuels, Green Energy